Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Ovarian Neoplasms 8Fallopian Tube Neoplasms 3Endometrial Neoplasms 3Breast Neoplasms 3Vulvar Neoplasms 2Vaginal Neoplasms 2Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Pain 2Lung Neoplasms 2Fatigue 2Depression 2Anxiety Disorders 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Sleep Wake Disorders 1Sleep Initiation and Maintenance Disorders 1Pseudomyxoma Peritonei 1Peritoneal Neoplasms 1Neoplasms 1Multiple Myeloma 1Mental Disorders 1Lymphoma 1Leydig Cell Tumor 1Leukemia 1Kidney Neoplasms 1Glioblastoma 1Gestational Trophoblastic Disease 1

Interventions

Reverse Transcriptase Polymerase Chain Reaction 1Radiosurgery 1Psychiatric Rehabilitation 1Pharmacogenomic Testing 1Methods 1Gene Expression Profiling 1Gemcitabine 1Early Intervention, Educational 1Carboplatin 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leydig Cell Tumor × Behavior Therapy × Gynecologic × Clear all
NCT01764789 2015-10-09

Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Completed
39 enrolled
BreastGynecologic

Carcinoma, Ovarian Epithelial, Anxiety Disorders, Breast Neoplasms, Uterine Cervical Neoplasms, Depression, Fallopian Tube Neoplasms, Fatigue, Leydig Cell Tumor, Pain, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡